News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
21,777 Results
Type
Article (1396)
Company Profile (2)
Press Release (20379)
Section
Business (6693)
Career Advice (28)
Deals (1663)
Drug Delivery (2)
Drug Development (2712)
Employer Resources (9)
FDA (584)
Job Trends (706)
News (11736)
Policy (1072)
Tag
Academia (56)
Accelerated approval (2)
Allergies (8)
Alliances (1860)
ALS (3)
Alzheimer's disease (52)
Antibody-drug conjugate (ADC) (9)
Approvals (621)
Artificial intelligence (17)
Autoimmune disease (4)
Bankruptcy (24)
Best Places to Work (580)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (2)
Bladder cancer (5)
Brain cancer (1)
Breast cancer (9)
Cancer (149)
Cardiovascular disease (58)
Career advice (28)
CAR-T (7)
CDC (1)
Cell therapy (16)
Cervical cancer (1)
Clinical research (2476)
Collaboration (51)
Compensation (9)
Complete response letters (2)
COVID-19 (92)
CRISPR (16)
C-suite (36)
Cystic fibrosis (1)
Data (233)
Diabetes (11)
Diagnostics (90)
Diversity, equity & inclusion (4)
Drug discovery (6)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (2304)
Editorial (1)
Employer branding (5)
Employer resources (9)
Events (2243)
Executive appointments (42)
FDA (715)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (1)
Funding (116)
Gene editing (19)
Generative AI (2)
Gene therapy (25)
GLP-1 (24)
Government (99)
Guidances (15)
Healthcare (431)
IgA nephropathy (3)
Immunology and inflammation (9)
Immuno-oncology (4)
Indications (7)
Infectious disease (99)
Inflammatory bowel disease (3)
Influenza (3)
Intellectual property (8)
IPO (674)
Job creations (135)
Job search strategy (23)
JPM (1)
Labor market (10)
Layoffs (54)
Leadership (3)
Legal (363)
Liver cancer (9)
Lung cancer (24)
Lymphoma (20)
Machine learning (2)
Management (1)
Manufacturing (18)
MASH (3)
Medical device (216)
Medtech (216)
Mergers & acquisitions (1060)
Metabolic disorders (26)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (7)
Neuropsychiatric disorders (1)
Neuroscience (83)
NextGen: Class of 2026 (210)
Non-profit (68)
Obesity (9)
Opinion (7)
Ovarian cancer (1)
Pain (4)
Pancreatic cancer (2)
Parkinson's disease (10)
Patents (4)
Patient recruitment (11)
Peanut (3)
People (2243)
Pharmaceutical (2)
Phase 1 (687)
Phase 2 (913)
Phase 3 (1024)
Pipeline (213)
Policy (6)
Postmarket research (169)
Preclinical (198)
Prostate cancer (19)
Radiopharmaceuticals (13)
Rare diseases (22)
Real estate (140)
Recruiting (3)
Regulatory (769)
Reports (3)
Research institute (53)
Resumes & cover letters (5)
RSV (4)
Schizophrenia (3)
Series A (18)
Series B (13)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (1)
Startups (253)
Supply chain (5)
The Weekly (9)
Vaccines (23)
Venture capital (7)
Weight loss (6)
Women's health (13)
Worklife (1)
Date
Last 7 days (19)
Last 30 days (62)
Last 365 days (978)
2026 (90)
2025 (989)
2024 (1186)
2023 (1249)
2022 (2026)
2021 (2028)
2020 (1630)
2019 (1393)
2018 (1015)
2017 (1066)
2016 (982)
2015 (1140)
2014 (831)
2013 (695)
2012 (677)
2011 (777)
2010 (671)
Location
Africa (22)
Alabama (1)
Arizona (5)
Asia (1107)
Australia (173)
California (338)
Canada (76)
China (37)
Colorado (13)
Connecticut (24)
Delaware (14)
Europe (3976)
Florida (53)
Georgia (26)
Hawaii (1)
Idaho (2)
Illinois (18)
India (5)
Indiana (21)
Japan (8)
Kansas (3)
Kentucky (2)
Louisiana (2)
Maine (4)
Maryland (39)
Massachusetts (228)
Michigan (10)
Minnesota (14)
Mississippi (1)
Missouri (7)
Nebraska (1)
Nevada (1)
New Jersey (118)
New York (158)
North Carolina (34)
Northern California (152)
Ohio (8)
Pennsylvania (66)
Puerto Rico (1)
Rhode Island (1)
South America (27)
Southern California (154)
Tennessee (4)
Texas (59)
United States (1237)
Utah (11)
Virginia (7)
Washington D.C. (3)
Washington State (17)
West Virginia (1)
21,777 Results for "bayer cropscience lp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
The nod brings Bayer face-to-face in the market with Boehringer Ingelheim and AstraZeneca, each of which has its own HER2 blocker for non-small cell lung cancer.
November 20, 2025
·
1 min read
·
Tristan Manalac
Layoffs
Bayer Layoffs Continued in Q3 but CEO Says Cuts Should Be ‘Incremental’ Moving Forward
Bayer has let go of about 13,500 employees, including around 5,000 managers, since implementing a new operating model in early 2024. CEO Bill Anderson said in a recent earnings call that he expects a slower rate of headcount reduction moving forward.
November 14, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo
February 5, 2026
·
8 min read
Press Releases
Bayer Accelerates Pharma Growth on High-Value Portfolio
January 14, 2026
·
13 min read
Press Releases
Lantern Pharma’s LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
January 20, 2026
·
9 min read
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
January 20, 2026
·
4 min read
Cancer
Exelixis Beats Bayer in Colorectal Cancer as Zanzalintinib Delivers ‘First Pivotal Success’
In combination with Roche’s PD-L1 blocker Tecentriq, zanzalintinib bested Bayer’s Stivarga. Exelixis is positioning the drug candidate as a successor to cabozantinib, which is set to lose patent exclusivity in 2030.
June 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
January 28, 2026
·
4 min read
Press Releases
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
January 7, 2026
·
4 min read
1 of 2,178
Next
